Dyne Therapeutics Inc (DYN)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -116.376 | -120.296 | -32.148 | -38.329 | -45.929 | -100.099 |
Return on Equity (%) | 197.213 | -324.539 | -33.354 | -42.02 | -54.176 | -137.31 |
Return on Invested Capital (%) | -229.316 | -153.392 | -33.142 | -42.503 | -55.513 | -142.859 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 1.982 | 5.426 | 7.595 | 7.134 | 4.862 | 1.487 |
Earnings Per Share | -2.28 | -5.744 | -1.319 | -2.893 | -3.238 | -3.844 |
Cash Per Share | 3.85 | 5.656 | 6.674 | 3.891 | 3.316 | 1.982 |
Working Capital Per Share | 3.529 | 4.794 | 7.501 | 6.853 | 4.576 | 1.275 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -2.28 | -5.744 | -1.319 | -2.893 | -3.238 | -3.844 |
EBITDA Per Share | -2.28 | -5.744 | -1.319 | -2.893 | -3.238 | -3.844 |
Free Cash Flow Per Share | -2.228 | -5.212 | -1.308 | -2.844 | -3.212 | -3.86 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,11M | 2,59M | 45,08M | N/A | N/A | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,38B |
Ratio cours/bénéfice | -6,03 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 11,7 |
Ratio prix/valeur comptable | 15,58 |
Rendement de dividende | - |
Actions en circulation | 101,77M |
Volume moyen (1 semaine) | 4,88M |
Volume moyen (1 mois) | 3,14M |
Variation sur 52 semaines | -32,46% |
Plus haut sur 52 semaines | 47,45 |
Plus bas sur 52 semaines | 13,235 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales